Cell Cycle Deregulation in Cancer

Nonfiction, Health & Well Being, Medical, Specialties, Oncology, Medical Science, Pharmacology
Cover of the book Cell Cycle Deregulation in Cancer by , Springer New York
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781441917706
Publisher: Springer New York Publication: March 10, 2010
Imprint: Springer Language: English
Author:
ISBN: 9781441917706
Publisher: Springer New York
Publication: March 10, 2010
Imprint: Springer
Language: English

Cancer is fundamentally a disease of abnormal cell proliferation: Cancer cells multiply when and where they should not. This proliferation entails escape from normal bounds imposed by the tissue environment, the internal biology of the cell (DNA damage, chromosomal imbalances, disorganized mitotic spindles), and the proliferative history of the cell (normal generational times). Some of the key oncogenic events in cancer directly perturb proteins that regulate progression through the cell division cycle, others alter cell cycle progression indirectly, through effects on signaling pathway that impinge on the cell cycle. This biology is fundamentally important in cancer therapy. Many of the workhorse treatments for cancer rely on killing proliferating cells. Furthermore, there is growing recognition that stem cell-transit amplifying cell hierarchies may persist or be generated during tumorigenesis, generating important functional heterogeneity in cell cycle control among tumor cells, with far-reaching scientific and clinical implications. This volume outlines major cell cycle perturbations that drive tumorigenesis and considers the prospects for using such knowledge in cancer therapy.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Cancer is fundamentally a disease of abnormal cell proliferation: Cancer cells multiply when and where they should not. This proliferation entails escape from normal bounds imposed by the tissue environment, the internal biology of the cell (DNA damage, chromosomal imbalances, disorganized mitotic spindles), and the proliferative history of the cell (normal generational times). Some of the key oncogenic events in cancer directly perturb proteins that regulate progression through the cell division cycle, others alter cell cycle progression indirectly, through effects on signaling pathway that impinge on the cell cycle. This biology is fundamentally important in cancer therapy. Many of the workhorse treatments for cancer rely on killing proliferating cells. Furthermore, there is growing recognition that stem cell-transit amplifying cell hierarchies may persist or be generated during tumorigenesis, generating important functional heterogeneity in cell cycle control among tumor cells, with far-reaching scientific and clinical implications. This volume outlines major cell cycle perturbations that drive tumorigenesis and considers the prospects for using such knowledge in cancer therapy.

More books from Springer New York

Cover of the book South Asian Mammals by
Cover of the book Primates, Pathogens, and Evolution by
Cover of the book The Rho GTPases in Cancer by
Cover of the book Drug Resistance in Cancer Cells by
Cover of the book Orthopedic Infection by
Cover of the book Fundamentals of Neurologic Disease by
Cover of the book Mobility Data Management and Exploration by
Cover of the book Astronomy and the Climate Crisis by
Cover of the book Psychiatric Diagnosis by
Cover of the book Advances in Biology and Therapy of Multiple Myeloma by
Cover of the book The Organizational Sweet Spot by
Cover of the book Extreme Explosions by
Cover of the book Pediatric Cochlear Implantation by
Cover of the book Integrating Routing Decisions in Public Transportation Problems by
Cover of the book Cognitive Strategy Research by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy